Wednesday, November 25, 2015 2:12:40 AM
Rosen tried to make the paragraph below sound scary, but it is not very impressive. Take note of the wording of the last sentence. It says that they HAVE additional information that IF it is investigated further
MIGHT result in discovering something negative about the defendants.
As to the rest of it, I don't know that either of the other factors mentioned in the paragraph, even if true, would be enough to sustain a cause of action. Just being "affiliated" with "stock promoters" and other "failed companies" certainly would not be enough.
As to the claim that Menon "exaggerated" his role at Eli Lily; he apparently did win a significant award during his time at Eli Lily so that claim seems unlikely to be true. And "falsely" claiming they had prominent advisors is apparently referring to Emil Frie. Hopefully, Leo or Dr. M has an email trail with Dr. Frie that says otherwise. But again, I find it hard to believe that any of this is enough to sustain a cause of action.
This whole letter is just deliberate obfuscation in the hope that the Judge will allow Rosen to embark upon a long and costly fishing expedition that they can leverage into a settlement.
From the Rosen response...
"It is difficult to get a man to understand something, when his salary depends upon his not understanding it."
Upton Sinclair
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM